Company intelligence / Profile preview

Frontier Scientific

Newark, Delaware, United Statesfrontierscientific.com ↗

Ownership: Private
Employees: ~62
Development stage: Other

Overview

Frontier Scientific was a leading CRO specializing in outsourced chemical materials management, sample reformatting, and distribution for pharmaceutical and biotechnology R&D organizations. The company enabled cost savings and improved productivity for clients by managing proprietary compound collections, supporting over 120 organizations globally with more than 15 million compounds under management. In 2022, it was acquired by eMolecules to create an integrated solution for chemical procurement and sample management in early drug discovery research[1][2].

Modalities: Small molecule
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Frontier Scientific.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Frontier Scientific.

Explore the full profile